Cargando…
High performance methylated DNA markers for detection of colon adenocarcinoma
BACKGROUND: Colon cancer (CC) is treatable if detected in its early stages. Improved CC detection assays that are highly sensitive, specific, and available at point of care are needed. In this study, we systematically selected and tested methylated markers that demonstrate high sensitivity and speci...
Autores principales: | Klein Kranenbarg, Romy A. M., Vali, Abdul Hussain, IJzermans, Jan N. M., Pisanic, Thomas R., Wang, Tza-Huei, Azad, Nilofer, Sukumar, Saraswati, Fackler, Mary Jo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670296/ https://www.ncbi.nlm.nih.gov/pubmed/34903270 http://dx.doi.org/10.1186/s13148-021-01206-2 |
Ejemplares similares
-
A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype
por: Baretti, Marina, et al.
Publicado: (2021) -
Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer
por: Fackler, Mary Jo, et al.
Publicado: (2022) -
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer
por: Fackler, Mary Jo, et al.
Publicado: (2020) -
Multiplex Digital Methylation‐Specific PCR for Noninvasive Screening of Lung Cancer
por: Zhao, Yang, et al.
Publicado: (2023) -
Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers
por: Miller, Brendan F., et al.
Publicado: (2020)